机构:[1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University, and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing 100053, China首都医科大学宣武医院[2]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing 100069, China
第一作者机构:[1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University, and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing 100053, China[2]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing 100069, China
通讯作者:
通讯机构:[1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University, and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing 100053, China[2]Center of Neural Injury and Repair, Beijing Institute for Brain Disorders, Beijing 100069, China
推荐引用方式(GB/T 7714):
CHEN ZhiGuo,ZHANG Y. Alex.Cell therapy for macular degeneration-first phase I/II pluripotent stem cell-based clinical trial shows promise[J].SCIENCE CHINA-LIFE SCIENCES.2015,58(1):119-120.doi:10.1007/s11427-014-4791-2.
APA:
CHEN ZhiGuo&ZHANG Y. Alex.(2015).Cell therapy for macular degeneration-first phase I/II pluripotent stem cell-based clinical trial shows promise.SCIENCE CHINA-LIFE SCIENCES,58,(1)